148 related articles for article (PubMed ID: 37179272)
1. ASO Author Reflections: Timing of Systemic Therapy and Postoperative Morbidity in Resectable Pancreatic Ductal Adenocarcinoma and Distal Cholangiocarcinoma.
Macfie R; Cohen N
Ann Surg Oncol; 2023 Aug; 30(8):5035. PubMed ID: 37179272
[No Abstract] [Full Text] [Related]
2. Intra-pancreatic distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: a common short and long-term prognosis?
Guilbaud T; Girard E; Lemoine C; Schlienger G; Alao O; Risse O; Berdah S; Chirica M; Moutardier V; Birnbaum DJ
Updates Surg; 2021 Apr; 73(2):439-450. PubMed ID: 33486711
[TBL] [Abstract][Full Text] [Related]
3. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
Byrling J; Ghazi S; Andersson B
BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
[TBL] [Abstract][Full Text] [Related]
4. ASO Author Reflections: Accuracy of Preoperative Staging and Downstaging After Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma.
Alaimo L; Lima HA; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Aug; 30(8):4809-4810. PubMed ID: 37046130
[No Abstract] [Full Text] [Related]
5. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.
Gandou C; Harada K; Sato Y; Igarashi S; Sasaki M; Ikeda H; Nakanuma Y
Hum Pathol; 2013 May; 44(5):811-21. PubMed ID: 23134772
[TBL] [Abstract][Full Text] [Related]
6. Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma.
Macfie R; Berger Y; Liu H; Li T; Imtiaz S; Ang C; Sarpel U; Hiotis S; Labow D; Golas B; Cohen NA
Ann Surg Oncol; 2023 Aug; 30(8):5027-5034. PubMed ID: 37210446
[TBL] [Abstract][Full Text] [Related]
7. ASO Author Reflections: Role of Neoadjuvant Therapy in Surgically Resectable Intrahepatic Cholangiocarcinoma.
Mason MC; Tran Cao HS
Ann Surg Oncol; 2021 Oct; 28(11):6736-6737. PubMed ID: 33452608
[No Abstract] [Full Text] [Related]
8. Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic carcinoma.
Freeny PC
Ann Oncol; 1999; 10 Suppl 4():12-7. PubMed ID: 10436776
[TBL] [Abstract][Full Text] [Related]
9. Synchronous occurrence of gastrointestinal stromal tumor, pancreatic intraductal papillary mucinous neoplasm, and intrahepatic cholangiocarcinoma: Case report.
Hou Q; Zhang W; Niu J; Tian M; Liu J; Cui L; Li Y
Medicine (Baltimore); 2022 Jul; 101(28):e29460. PubMed ID: 35839023
[TBL] [Abstract][Full Text] [Related]
10. ASO Author Reflections: Bile Duct Resection-Is It Beneficial for Distal Cholangiocarcinoma?
Ebata T; Jikei K; Mizuno T
Ann Surg Oncol; 2021 Apr; 28(4):2000. PubMed ID: 33094374
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Intrahepatic Cholangiocarcinoma: Downstaging Strategies Open the Gate to Surgery and Cure.
Boudjema K; Edeline J
Ann Surg Oncol; 2020 Oct; 27(10):3738-3739. PubMed ID: 32314152
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Disparate Outcomes in Stage II Intrahepatic Cholangiocarcinoma: A Case for Upstaging Multifocal Tumors.
Turner KM; Wilson GC
Ann Surg Oncol; 2022 Aug; 29(8):5103-5104. PubMed ID: 35482267
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Use of Machine Learning to Predict Early Recurrence After Resection of Intrahepatic Cholangiocarcinoma.
Alaimo L; Pawlik TM
Ann Surg Oncol; 2023 Sep; 30(9):5416-5417. PubMed ID: 37222944
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Incorporating Circulating Tumor DNA in Perioperative Management of Intrahepatic Cholangiocarcinoma.
Choi WJ; Sapisochin G; O'Kane GM
Ann Surg Oncol; 2023 Jun; 30(6):3864-3865. PubMed ID: 36752965
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Impact of Tumor Necrosis on Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma.
Tsilimigras DI; Pawlik TM
Ann Surg Oncol; 2022 May; 29(5):2975-2976. PubMed ID: 35217976
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Identification of Intrahepatic Cholangiocarcinoma Clusters Using Machine Learning Techniques: Should Patients be Treated Differently?
Tsilimigras DI; Paredes AZ; Pawlik TM
Ann Surg Oncol; 2020 Dec; 27(13):5233-5234. PubMed ID: 32591955
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: A New Reliable Method of Evaluating Cancer-Associated Fibroblasts in Resected Specimen of Intrahepatic Cholangiocarcinoma.
Eguchi S; Yamada D; Kobayashi S; Sasaki K; Iwagami Y; Tomimaru Y; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H
Ann Surg Oncol; 2023 Sep; 30(9):5429-5430. PubMed ID: 37273026
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Panoramic Histologic Patterns of Caudate Lobe Invasion in Hilar Cholangiocarcinoma.
Jiang N; Xiang CH; Wang SY; Jin S
Ann Surg Oncol; 2022 Oct; 29(11):6813-6814. PubMed ID: 35668308
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: The New Age of Minimally Invasive Perihilar Cholangiocarcinoma.
Lopez-Lopez V; Robles-Campos R
Ann Surg Oncol; 2024 Mar; 31(3):1840-1841. PubMed ID: 38071711
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status in Patients with Intrahepatic Cholangiocarcinoma.
Endo Y; Moazzam Z; Lima HA; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):2033-2034. PubMed ID: 36396871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
